ReShape Lifesciences Inc. (RSLS) reports Q1 results

ReShape Lifesciences Inc. (NASDAQ: RSLS) reported Q1 results. Revenue for the quarter came in at $2.29 million versus the consensus estimate of $3.92 million.

For earnings history and earnings-related data on ReShape Lifesciences Inc. (RSLS) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• DeFi Technologies (DEFT) PT Lowered to $1 at Benchmark Following Q2 Miss
• GLJ Research on Sell Rated Tesla (TSLA): 'We now see FSD as the main reason TSLA’s stock will bleed lower this year'